{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:11:30Z","timestamp":1790687490628,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670201, 81870161"],"award-info":[{"award-number":["81670201, 81870161"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin City","doi-asserted-by":"publisher","award":["16JCYBJC42600"],"award-info":[{"award-number":["16JCYBJC42600"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2020,1,23]]},"DOI":"10.1038\/s41388-019-1037-6","type":"journal-article","created":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T05:28:50Z","timestamp":1569994130000},"page":"922-934","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Proteasome inhibitor induced SIRT1 deacetylates GLI2 to enhance hedgehog signaling activity and drug resistance in multiple myeloma"],"prefix":"10.1038","volume":"39","author":[{"given":"Ying","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiguo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0677-8097","authenticated-orcid":false,"given":"Zhiqiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,1]]},"reference":[{"key":"1037_CR1","doi-asserted-by":"publisher","first-page":"17046","DOI":"10.1038\/nrdp.2017.46","volume":"3","author":"SK Kumar","year":"2017","unstructured":"Kumar SK, Rajkumar V, Kyle RA, van Duin M, Sonneveld P, Mateos MV, et al. Multiple myeloma. Nat Rev Dis Primers. 2017;3:17046.","journal-title":"Nat Rev Dis Primers"},{"key":"1037_CR2","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1056\/NEJMe1407442","volume":"371","author":"D Avigan","year":"2014","unstructured":"Avigan D, Rosenblatt J. Current treatment for multiple myeloma. New Engl J Med. 2014;371:961\u20132.","journal-title":"New Engl J Med"},{"key":"1037_CR3","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ctrv.2018.09.001","volume":"70","author":"P Robak","year":"2018","unstructured":"Robak P, Drozdz I, Szemraj J, Robak T. Drug resistance in multiple myeloma. Cancer Treat Rev. 2018;70:199\u2013208.","journal-title":"Cancer Treat Rev"},{"key":"1037_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/bjh.15210","volume":"182","author":"CT Wallington-Beddoe","year":"2018","unstructured":"Wallington-Beddoe CT, Sobieraj-Teague M, Kuss BJ, Pitson SM. Resistance to proteasome inhibitors and other targeted therapies in myeloma. Br J Haematol. 2018;182:11\u201328.","journal-title":"Br J Haematol"},{"key":"1037_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.ajpath.2011.09.009","volume":"180","author":"CY Ok","year":"2012","unstructured":"Ok CY, Singh RR, Vega F. Aberrant activation of the hedgehog signaling pathway in malignant hematological neoplasms. Am J Pathol. 2012;180:2\u201311.","journal-title":"Am J Pathol"},{"key":"1037_CR6","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1182\/blood-2014-03-557298","volume":"124","author":"Z Liu","year":"2014","unstructured":"Liu Z, Xu J, He J, Zheng Y, Li H, Lu Y, et al. A critical role of autocrine sonic hedgehog signaling in human CD138+ myeloma cell survival and drug resistance. Blood. 2014;124:2061\u201371.","journal-title":"Blood"},{"key":"1037_CR7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/onc.2012.544","volume":"33","author":"Z Liu","year":"2014","unstructured":"Liu Z, Li T, Reinhold MI, Naski MC. MEK1-RSK2 contributes to Hedgehog signaling by stabilizing GLI2 transcription factor and inhibiting ubiquitination. Oncogene. 2014;33:65\u201373.","journal-title":"Oncogene"},{"key":"1037_CR8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/17474086.2017.1280388","volume":"10","author":"JP Laubach","year":"2017","unstructured":"Laubach JP, San-Miguel JF, Hungria V, Hou J, Moreau P, Lonial S, et al. Deacetylase inhibitors: an advance in myeloma therapy? Expert Rev Hematol. 2017;10:229\u201337.","journal-title":"Expert Rev Hematol"},{"key":"1037_CR9","doi-asserted-by":"crossref","unstructured":"Cappellacci L, Perinelli DR, Maggi F, Grifantini M, Petrelli R. Recent progress in histone deacetylase inhibitors as anticancer agents. Curr Med Chem. 2018;25:1.","DOI":"10.2174\/0929867325666181016163110"},{"key":"1037_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-018-0119-y","volume":"8","author":"H Ohguchi","year":"2018","unstructured":"Ohguchi H, Hideshima T, Anderson KC. The biological significance of histone modifiers in multiple myeloma: clinical applications. Blood Cancer J. 2018;8:83.","journal-title":"Blood Cancer J"},{"key":"1037_CR11","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.clml.2018.05.023","volume":"18","author":"V Yazbeck","year":"2018","unstructured":"Yazbeck V, Shafer D, Perkins EB, Coppola D, Sokol L, Richards KL, et al. A phase II trial of bortezomib and vorinostat in mantle cell lymphoma and diffuse large B-cell lymphoma. Clin Lymphoma Myeloma Leuk. 2018;18:569\u2013575. e561.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"1037_CR12","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.3109\/10428194.2012.661175","volume":"53","author":"JL Wolf","year":"2012","unstructured":"Wolf JL, Siegel D, Goldschmidt H, Hazell K, Bourquelot PM, Bengoudifa BR, et al. Phase II trial of the pan-deacetylase inhibitor panobinostat as a single agent in advanced relapsed\/refractory multiple myeloma. Leuk Lymphoma. 2012;53:1820\u20133.","journal-title":"Leuk Lymphoma"},{"key":"1037_CR13","first-page":"729","volume":"17","author":"S Islam","year":"2019","unstructured":"Islam S, Abiko Y, Uehara O, Chiba I. Sirtuin 1 and oral cancer. Oncol Lett. 2019;17:729\u201338.","journal-title":"Oncol Lett"},{"key":"1037_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/1868-7083-4-5","volume":"4","author":"GP Delcuve","year":"2012","unstructured":"Delcuve GP, Khan DH, Davie JR. Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors. Clin Epigenetics. 2012;4:5.","journal-title":"Clin Epigenetics"},{"key":"1037_CR15","doi-asserted-by":"publisher","first-page":"950","DOI":"10.3390\/ijms16010950","volume":"16","author":"GE Simmons Jr.","year":"2015","unstructured":"Simmons GE, Jr. Pruitt WM, Pruitt K. Diverse roles of SIRT1 in cancer biology and lipid metabolism. Int J Mol Sci. 2015;16:950\u201365.","journal-title":"Int J Mol Sci"},{"key":"1037_CR16","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ncb2013","volume":"12","author":"G Canettieri","year":"2010","unstructured":"Canettieri G, Di Marcotullio L, Greco A, Coni S, Antonucci L, Infante P, et al. Histone deacetylase and Cullin3-REN(KCTD11) ubiquitin ligase interplay regulates Hedgehog signalling through Gli acetylation. Nat Cell Biol. 2010;12:132\u201342.","journal-title":"Nat Cell Biol"},{"key":"1037_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/B978-0-12-394622-5.00009-2","volume":"88","author":"A Gulino","year":"2012","unstructured":"Gulino A, Di Marcotullio L, Canettieri G, De Smaele E, Screpanti I. Hedgehog\/Gli control by ubiquitination\/acetylation interplay. Vitam Horm. 2012;88:211\u201327.","journal-title":"Vitam Horm"},{"key":"1037_CR18","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/j.1365-2141.2011.08888.x","volume":"155","author":"D Chauhan","year":"2011","unstructured":"Chauhan D, Bandi M, Singh AV, Ray A, Raje N, Richardson P, et al. Preclinical evaluation of a novel SIRT1 modulator SRT1720 in multiple myeloma cells. Br J Haematol. 2011;155:588\u201398.","journal-title":"Br J Haematol"},{"key":"1037_CR19","doi-asserted-by":"publisher","first-page":"29854","DOI":"10.1074\/jbc.M115.664953","volume":"290","author":"B Li","year":"2015","unstructured":"Li B, Fu J, Chen P, Ge X, Li Y, Kuiatse I, et al. The nuclear factor (erythroid-derived 2)-like 2 and proteasome maturation protein axis mediate bortezomib resistance in multiple myeloma. J Biol Chem. 2015;290:29854\u201368.","journal-title":"J Biol Chem"},{"key":"1037_CR20","doi-asserted-by":"crossref","first-page":"60684","DOI":"10.18632\/oncotarget.19527","volume":"8","author":"L Armas-Lopez","year":"2017","unstructured":"Armas-Lopez L, Zuniga J, Arrieta O, Avila-Moreno F. The Hedgehog-GLI pathway in embryonic development and cancer: implications for pulmonary oncology therapy. Oncotarget. 2017;8:60684\u2013703.","journal-title":"Oncotarget"},{"key":"1037_CR21","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1038\/480S43a","volume":"480","author":"C Delude","year":"2011","unstructured":"Delude C. Tumorigenesis: testing ground for cancer stem cells. Nature. 2011;480:S43\u20135.","journal-title":"Nature"},{"key":"1037_CR22","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1182\/blood-2002-02-0376","volume":"100","author":"D Chauhan","year":"2002","unstructured":"Chauhan D, Catley L, Hideshima T, Li G, Leblanc R, Gupta D, et al. 2-Methoxyestradiol overcomes drug resistance in multiple myeloma cells. Blood. 2002;100:2187\u201394.","journal-title":"Blood"},{"key":"1037_CR23","doi-asserted-by":"crossref","first-page":"34329","DOI":"10.18632\/oncotarget.6020","volume":"6","author":"Z Liu","year":"2015","unstructured":"Liu Z, Xu J, He J, Liu H, Lin P, Wan X, et al. Mature adipocytes in bone marrow protect myeloma cells against chemotherapy through autophagy activation. Oncotarget. 2015;6:34329\u201341.","journal-title":"Oncotarget"},{"issue":"11","key":"1037_CR24","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3390\/cells7110208","volume":"7","author":"Ita Novita Sari","year":"2018","unstructured":"Sari IN, Phi LTH, Jun N, Wijaya YT, Lee S, Kwon HY. Hedgehog signaling in cancer: a prospective therapeutic target for eradicating cancer stem cells. Cells. 2018;7:pii E208.","journal-title":"Cells"},{"issue":"12","key":"1037_CR25","doi-asserted-by":"publisher","first-page":"4036","DOI":"10.3390\/ijms19124036","volume":"19","author":"Toni Nunes","year":"2018","unstructured":"Nunes T, Hamdan D, Leboeuf C, El Bouchtaoui M, Gapihan G, Nguyen TT, et al. Targeting cancer stem cells to overcome chemoresistance. Int J Mol Sci. 2018;19:pii E4036.","journal-title":"International Journal of Molecular Sciences"},{"key":"1037_CR26","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.celrep.2013.12.003","volume":"6","author":"P Niewiadomski","year":"2014","unstructured":"Niewiadomski P, Kong JH, Ahrends R, Ma Y, Humke EW, Khan S, et al. Gli protein activity is controlled by multisite phosphorylation in vertebrate Hedgehog signaling. Cell Rep. 2014;6:168\u201381.","journal-title":"Cell Rep"},{"key":"1037_CR27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/B978-0-12-394622-5.00004-3","volume":"88","author":"M Hatayama","year":"2012","unstructured":"Hatayama M, Aruga J. Gli protein nuclear localization signal. Vitam Horm. 2012;88:73\u201389.","journal-title":"Vitam Horm"},{"key":"1037_CR28","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1038\/leu.2017.144","volume":"31","author":"T Harada","year":"2017","unstructured":"Harada T, Ohguchi H, Grondin Y, Kikuchi S, Sagawa M, Tai YT, et al. HDAC3 regulates DNMT1 expression in multiple myeloma: therapeutic implications. Leukemia. 2017;31:2670\u20137.","journal-title":"Leukemia"},{"key":"1037_CR29","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1158\/1535-7163.MCT-15-0985","volume":"15","author":"N Amodio","year":"2016","unstructured":"Amodio N, Stamato MA, Gulla AM, Morelli E, Romeo E, Raimondi L, et al. Therapeutic targeting of miR-29b\/HDAC4 epigenetic loop in multiple myeloma. Mol Cancer Ther. 2016;15:1364\u201375.","journal-title":"Mol Cancer Ther"},{"key":"1037_CR30","doi-asserted-by":"publisher","first-page":"500","DOI":"10.3389\/fonc.2018.00500","volume":"8","author":"EA Zaal","year":"2018","unstructured":"Zaal EA, Berkers CR. The influence of metabolism on drug response in cancer. Front Oncol. 2018;8:500.","journal-title":"Front Oncol"},{"key":"1037_CR31","doi-asserted-by":"publisher","first-page":"353ra113","DOI":"10.1126\/scitranslmed.aad8949","volume":"8","author":"H Liu","year":"2016","unstructured":"Liu H, Liu Z, Du J, He J, Lin P, Amini B, et al. Thymidine phosphorylase exerts complex effects on bone resorption and formation in myeloma. Sci Transl Med. 2016;8:353ra113.","journal-title":"Sci Transl Med"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41388-019-1037-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-019-1037-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-019-1037-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:17:53Z","timestamp":1684617473000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-019-1037-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,1]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,1,23]]}},"alternative-id":["1037"],"URL":"https:\/\/doi.org\/10.1038\/s41388-019-1037-6","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,1]]},"assertion":[{"value":"22 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}